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Abstract
Background: In our study, we investigated whether circulating T follicular helper (Tfh) and the related cytokines are
involved in human cystic echinococcosis (CE).
Methods: A total of 64 patients with CE and 30 healthy controls were enrolled in this study. Percentages of
CCR7loPD-1hi cells within CXCR5+ CD4+ T cells (circulating Tfh cells) were detected by flow cytometry. Levels of
IL-21 and IL-4 in peripheral blood were detected by cytometric bead array. The mRNA expression of IL-21, IL-4,
Bcl-6, and Blimp-1 in peripheral blood mononuclear cells (PBMCs) were measured by real-time PCR. Levels of IgG1,
IgG2, IgG3, and IgG4 in the patients’ sera were measured using enzyme-linked immunosorbent assay.
Results: Percentages of circulating Tfh cells were significantly increased in the CE1, CE2, and CE3 groups (p < 0.05).
The concentrations of IL-21 and IL-4 in the serum were significantly increased in CE1, CE2, and CE3 groups (p < 0.05).
IL-21 was positively correlated with circulating Tfh cells in CE3 group (r = 0.779, p < 0.05). The mRNA levels of IL-21, IL-4,
and Bcl-6 were increased in CE1, CE2, and CE3 groups. Levels of IgG1 and IgG4 in patients’ sera were increased in CE1,
CE2, and CE3 groups. Levels of IgG2 and IgG3 were increased in CE4-5 group. Additionally, after stimulation with
hydatid fluid in vitro, the levels of circulating Tfh cells, IL-21 and IL-4 in PBMCs isolated from CE patients were
significantly increased (p < 0.05).
Conclusions: The levels of circulating Tfh and related cytokines were significantly increased in CE patients, suggesting
that they are involved in human CE.
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Background
Cystic echinococcosis (CE), also known as hydatidosis, is
a zoonotic parasitic disease with a high incidence in
Xinjiang, a pastoral area in China [1]. CE is caused by
parasitic larvae of Echinococcus granulosus (Eg) in the
intermediate hosts such as human and sheep [1–3]. Larvae
of Eg have a bladder-like morphology and parasitize the
parenchymas of internal organs, especially the liver and
lungs. The larval stage of Eg forms a cyst that is filled with
hydatid fluid (HF), and is surrounded by three membrane
layers. Antigen B of Eg (AgB) is one of the major immuno-
dominant antigens of HF [4]. Cysts can undergo structure
changes during the progression of the disease. Based on
the ultrasound image and morphological changes in the
structure of hepatic cystic, CE is classified into CE1-2
(activity), CE3 (transition), and CE4-5 (inactivity) types
[5, 6]. CE1-CE5 types are characterized by the appearance
of cyst contents and wall. In CE4 and CE5, the viability of
parasite tissue is very low, therefore, the CE4 and CE5 cyst
are considered inactive. In CE1 and CE2, it is likely that
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cysts contain viable Protoscolices, thus, the CE1 and CE2
cysts are considered as active. The CE3 cysts show the
collapse or detachment of the parent cyst wall [6].
The host immune responses to hydatid, especially anti-
body class switching, varies in different CE types. It was
found that the positive rates of IgG4 in patient sera were
increased in CE1, CE2, and CE3 types, but the positive
rates of IgG1 and IgG4 were decreased in CE4–5 types
[7]. Specific IgG1 and IgG4 against antigens of cyst fluid
are dominant in CE with positive antibodies in sera [8].
IgG1, IgG4, IgE, and IgM are dominant in serum of
patients with chronic infection, but with a relatively low
level in the inactive stage of Eg-infection [7, 9]. The
IgG1 and IgG4 are significantly decreased, but the IgG2
and IgG3 are significantly increased upon removal of
hydatid cyst. Mechanism of the antibody class switching
during hydatid disease is still unclear. Activities of Th1
and Th2 cells are involved in the chronic infectious
parasitic diseases [10, 11]. Imbalance of Th1/Th2 exists
in Eg-infection [12]. During the EG infection in humans,
Th1 immune responses are dominant in the early stage
of hydatid infection, and IL-2 and IFN-γ secreted by
Th1 cells are directly related with the slow growth of
hydatid. The Th2 immune responses become dominant
in the advanced stages, associated with rapid growth of
hydatid [13]. Activity of TGF-β/Smad signaling pathway
results in up-regulation of IL-10 and TGF-β, and imbal-
ance of Treg/Th17 [14]. Th9 cells are also involved in
the immune responses against Eg-infection [15]. Rela-
tionship between the Eg-infection and the newly identi-
fied CD4+ T cells subgroup called follicular helper CD4+
T (Tfh) cells is not reported.
Previous studies suggested that the maturation and
proliferation of B cell need the help of Tfh cells, which
localize to the germinal center of B-cell follicle in sec-
ondary lymphoid organ [16, 17]. Tfh cells, the subset of
CD4+ T cell expressing surface molecules of PD-1,
CXCR5 and ICOS, play a central role in antibody gener-
ation and class switching. Tfh cells secrete the IL-4 and
IL-21, cytokines that promote growth and differentiation
of B cells. Bcl-6 that is strongly up-regulated in Tfh cells
is identified as the master regulator of Tfh cells. The pri-
mary function of Bcl-6 in Tfh cells is to suppress the
genes that are required to drive the differentiation of
other Th cell lineages. Blimp-1, which antagonizes Bcl-6,
can inhibit Tfh cell formation. Thus, Tfh cell generation
is controlled by the balance of these two transcription
factor. Without Tfh cells, germinal center is hardly
formed and the humoral immune response by B cells is
significantly decreased, leading to studies on mechanism
of Tfh cells in humoral immune, such as virus infection,
autoimmune disease and parasite infection [13, 18–24].
Circulating Tfh cell is considered as the counterpart of
Tfh cells in the peripheral lymphoid organs [25–28].
Especially, He et al found that within circulating CXCR5+
CD4+ T cells, the CCR7loPD-1hi subset had a partial Tfh
effector phenotype [25]. Thus, CCR7loPD-1hi cells within
CXCR5+ CD4+ T cells in peripheral blood may serve as
circulating Tfh cells. The role of the circulating Tfh cells
in autoimmunity has been reported [20]. However, the
role of circulating Tfh cell in the CE patients is not
clear. Therefore, in the present study, we investigated
the changes in percentages of circulating Tfh cells in
peripheral blood of CE patients and the related cyto-
kines and transcription factors. Correlation between
circulating Tfh cells and antibody types of Eg-infection
was also investigated.
Methods
Healthy individuals and patients
A total of 64 patients and 30 healthy individuals as con-
trols were enrolled in this study and the detailed demo-
graphic information were included in the Table 1. No
individuals in this study received anti-inflammatory
drugs and patients with other diseases such as acute and
chronic viral infections, autoimmune diseases, tumors,
rheumatic diseases, sepsis, severe upper respiratory in-
fections, lung or biliary tract infection, or fever were ex-
cluded. This study was approved by the Human Ethics
Committee of the First Affiliated Hospital of Xinjiang
Medical University (approval number: 20120220-126).
All patients provided written informed consents.
Real-time reverse transcription polymerase chain reaction
(Real-time PCR)
Peripheral blood was collected from patients and healthy
individuals after fasting for 8 h. Then peripheral blood
mononuclear cells (PBMCs) were isolated and kept in li-
quid nitrogen for further analysis. Total RNA was ex-
tracted from PBMCs using Trizol LS reagent (Invitrogen,
Life Technologies, USA) and reverse transcribed into
cDNA by M-MLV Reverse Transcriptase (Invitrogen,
Carlsbad, CA, USA). Primers were shown in Table 2.
Real-time PCR was performed with the SYBR GREEN
PCR Premix (TaKaRa Biotechnology CO., Ltd., Dalian,
P.R. China) following the manufacturer's protocols. Target
genes and β-actin were amplified. The target genes were
quantified by Ct value using 2-ΔΔCt. Experiments were
repeated for at least 3 times.
Flow cytometry
PBMCs were isolated by differential centrifugation over
Ficoll-Hypaque, then suspended at 2 × 106/ml in RPMI-
1640 and added to two tubes (100 μl in each tube),
followed by addition of 5 μl monoclonal antibodies
conjugated with different fluorescent dyes, including
Vioblue-CD3, PERCP-CD4, PE-cy7-CCR7, FITC-CXCR5,
APC-CD45RA and PE-PD-1. Then, 5 μl PE-PD-1 or
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Table 1 Information of the patients enrolled in this study
Case Stages Age (range) Gender Position Size (cm) Populations
1 CE1 21–25 Male Left liver lobe 4.5 Han
2 CE1 21–25 Male Right liver lobe 4.1 Han
3 CE1 21–25 Male Left liver lobe 4.3 Han
4 CE1 31–35 Female Right liver lobe 5.6 Uighur
5 CE1 36–40 Female Right liver lobe 4.9 Kazak
6 CE1 26–30 Male Right liver lobe 5.6 Uighur
7 CE1 26–30 Male Right liver lobe 5.8 Uighur
8 CE1 21–25 Female Left liver lobe 4.6 Han
9 CE1 21–25 Male Left liver lobe 3.9 Kazak
10 CE1 36–40 Male Left liver lobe 6.8 Uighur
11 CE1 26–30 Female Right liver lobe 4.9 Uighur
12 CE1 31–35 Male Left liver lobe 5.9 Uighur
13 CE1 31–35 Female Right liver lobe 6.9 Han
14 CE1 36–40 Male Right liver lobe 7.9 Uighur
15 CE1 41–45 Male Right liver lobe 6.8 Uighur
16 CE1 36–40 Male Right liver lobe 5.9 Kazak
17 CE2 36–40 Female Right liver lobe 7.9 Kazak
18 CE2 36–40 Male Left liver lobe 4.9 Han
19 CE2 46–50 Male Left liver lobe 4.8 Kazak
20 CE2 31–35 Male Right liver lobe 6.9 Kazak
21 CE2 36–40 Male Left liver lobe 4.8 Uighur
22 CE2 31–35 Male Right liver lobe 7.9 Han
23 CE2 21–25 Female Right liver lobe 8.7 Han
24 CE2 31–35 Male Left liver lobe 8.9 Han
25 CE2 26–30 Male Right liver lobe, left liver lobe 8.6 Kazak
26 CE2 26–30 Male Left liver lobe 8.9 Han
27 CE2 31–35 Male Right liver lobe 8.7 Kazak
28 CE2 26–30 Female Right liver lobe 9.4 Han
29 CE2 36–40 Female Left liver lobe 10.6 Han
30 CE2 31–35 Male Right liver lobe 11.9 Han
31 CE2 26–30 Female Left liver lobe 15.6 Khalkhas
32 CE2 26–30 Male Right liver lobe 16.3 Kazak
33 CE2 31–35 Male Left liver lobe 18.9 Khalkhas
34 CE2 36–40 Female Right liver lobe 19.6 Kazak
35 CE2 26–30 Male Right liver lobe 20.9 Han
36 CE2 26–30 Female Right liver lobe 21.6 Khalkhas
37 CE2 21–25 Female Right liver lobe 12.3 Kazak
38 CE2 26–30 Male Left liver lobe 14.4 Uighur
39 CE2 31–35 Male Left liver lobe 7.6 Uighur
40 CE2 31–35 Female Right liver lobe 5.6 Uighur
41 CE3 45–50 Female Left liver lobe 7.8 Khalkhas
42 CE3 41–45 Female Right liver lobe 19.3 Khalkhas
43 CE3 36–40 Male Left liver lobe 12.3 Uighur
44 CE3 36–40 Female Right liver lobe 14.2 Uighur
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isotype control was added, followed by incubation for
20 min at 4 °C in dark. The cells were washed with PBS
and then centrifugated at 1000 rpm for 5 min. After
removing the supernatant, the cells were resuspended
in 500 μl PBS. After gating on SSC and FSC, cells with
positive expression of CD4 and CD3 were further
gated. The CD45RA−CXCR5+ cells were then gated
and CCR7loPD-1hi subset in CD45RA− CXCR5+ cells
was analyzed. More than 30,000 cells were collected
for each sample. Samples were detected by BD flow
cytometry (LSR II, BD, USA), and analyzed using
FLOWJo software.
Cytometric bead array
Expression levels of IL-21 and IL-4 were detected by cyto-
metric bead array according to instructions. Briefly, serum
sample (50 μl) was mixed with 50 μl of capture microbe-
ads and 50 μl of PE detection reagents (anti-human IL-21
and anti-human IL-4). After incubation for 3 h in the dark
at room temperature, samples were washed, rinsed with
300 μl serum enhanced buffer, and then detected. Levels
of IL-21 and IL-4 were detected by flow cytometry (LSR
II) and the data were analyzed using FCAP software.
Enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assay (ELISA) was per-
formed as previously described [8]. Briefly, microtiter
plates were coated with 6 μg/ml recombinant antigen B1
of Eg (AgB1) in bicarbonate buffer (pH 9.6) followed by
blocking with 5 % nonfat milk in neutral phosphate-
buffer saline containing 0.3 % Tween-20 (PBST). Serum
samples diluted with PBST were added to antigen-
coated wells in duplicate and incubated for 30 min at
37 °C. Positive and negative control sera were also in-
cluded. After washing with PBST, plates were incubated
with monoclonal mouse-anti-human-IgG1 (1:500), -IgG2
(1:50), -IgG3 (1:50), -IgG4 (1:500). HRP-labeled goat-anti-
mouse-IgG (1:1000 in PBS) were used as the secondary
antibody. Enzyme activity was assayed by incubation for
20 min at room temperature. The positive sera from CE
patients served as positive control. The sera from healthy
Table 1 Information of the patients enrolled in this study (Continued)
45 CE3 31–35 Male Right liver lobe, left liver lobe 8.4 Han
46 CE3 26–30 Male Left liver lobe 9.2 Tibetan
47 CE3 36–40 Male Left liver lobe 8.6 Han
48 CE3 31–35 Female Left liver lobe 7.6 Kazak
49 CE3 26–30 Male Right liver lobe 6.4 Han
50 CE3 26–30 Male Right liver lobe 12.3 Uighur
51 CE3 36–40 Male Right liver lobe 11.4 Uighur
52 CE3 31–35 Male Right liver lobe 8.3 Han
53 CE3 31–35 Male Right liver lobe 6.8 Uighur
54 CE3 31–35 Male Right liver lobe 11.6 Kazak
55 CE3 31–35 Female Right liver lobe 6.8 Han
56 CE3 36–40 Female Right liver lobe 7.9 Han
57 CE3 36–40 male Right liver lobe 8.6 Han
58 CE4-5 36–40 Male Right liver lobe 6.9 Han
59 CE4-5 41–45 Male Right liver lobe 8.7 Han
60 CE4-5 41–45 Male Right liver lobe 10.6 Mongolian
61 CE4-5 41–45 Male Right liver lobe 5.6 Mongolian
62 CE4-5 36–40 Male Right liver lobe 4.6 Uighur
63 CE4-5 36–40 Female Right liver lobe 4.8 Mongolian
64 CE4-5 41–45 Male Right liver lobe 9.4 Mongolian
Table 2 Primers used in this study
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individuals served as negative control. The absorbance
values at 450 nm wavelength were detected by a micro-
plate reader. The ODs values of IgGs were normalized to
those of negative control and the relative levels of IgGs
were compared among different groups.
In vitro stimulation of PBMCs
PBMCs were isolated from healthy individuals and CE pa-
tients with Ficoll. The cell concentration was adjusted to
1 × 106/ml in RPMI-1640. Then, 100 μl PBMCs suspen-
sion were added to a 96 well culture plate (1 × 105/well)
and cultured for 72 h. Then, PBMCs were co-cultured
with 10 ng/ml of IL-6 and 2 μg/ml of soluble anit-CD28
in the presence of HF or PBS at 37 °C with 5 % CO2. After
incubation for 72 h, cells and the culture supernatants
were collected. Percentage of the circulating Tfh cells was
detected with flow cytometry. Levels of IL-21 and IL-4 in
the culture supernatants were measured by cytometric
bead array.
Statistical analysis
All data were analyzed using SPSS 13.0 software. Results
were given as mean ± SD. One-way ANOVA was per-
formed to compare the differences between groups. Cor-
relation analysis was performed with Pearson correlation
analysis. P value less than 0.05 was considered as statisti-
cally significant.
Results
The frequency of CCR7loPD-1hi cells within CXCR5+ CD4+
T cells is increased in CE1, CE2, and CE3 groups
To determine expression of CCR7loPD-1hi T cells in
PBMCs from CE patients, flow cytometry analysis was
performed. CD45RA was used to identify the effector/
memory T cells (CD45RA−) in CD3+CD4+ T cells and
the cells positive for CXCR5 was further analyzed for
the percentage of Tfh cells expressing CCR7loPD-1hi
(Fig. 1). The results showed that the percentages of
CCR7loPD-1hi cells within CXCR5+ CD4+ T cells in CE1
(33.14 % ± 3.35), CE2 (34.58 % ± 4.00), and CE3 (31.95 % ±
4.84) group were significantly increased (p < 0.05) com-
pared with those in the healthy controls (13.54 % ± 3.89)
and in CE4-5 types (15.06 % ± 5.22). However, difference
between CE4-5 group and the healthy control group was
not statistically significant. Differences among CE1, CE2,
and CE3 groups were also not statistically significant. These
results indicated that percentages of CCR7loPD-1hi cells
within CXCR5+ CD4+ T cells are significantly higher in
CE1, CE2, and CE3 group patients than in healthy controls.
Levels of IL-21 and IL-4 in the sera from patients with
active disease are elevated
Cytometric bead array was performed to detect levels
of IL-21 in serum samples from the patients and
healthy controls. The results in Fig. 2 showed that,
Fig. 1 Increased frequency of CCR7loPD-1hi cells within CXCR5+ CD4+ T cells in CE patients. The PBMCs were stained with Vioblue-CD3, PERCP-CD4,
PE-cy7-CCR7, FITC-CXCR5 and APC-CD45RA. The percentages of CCR7loPD-1hi cells within CXCR5+CD4+ T cells were determined by flow cytometry
analysis. a Representative flow cytometry dot-plots of the percent of CD45RA−CXCR5+CD4+ T cells. b Quantification of phenotypic marker CCR7 and
PD-1 in each group. c The statistical results of percentage of CCR7loPD-1hi within CXCR5+ CD4+ T cells in each group
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compared with those in the healthy control group
(179.43 ± 31.54 pg/ml), levels of IL-21 were significantly
increased in CE1 (351.44 ± 43.78 pg/ml), CE2 (362.17 ±
37.34 pg/ml), and CE3 (338.94 ± 36.73 pg/ml) groups
(p < 0.05). However, the IL-21 level in CE4-5 (193.57 ±
21.08 pg/ml) was not different from that in healthy
controls. The difference among CE1, CE2, and CE3
types was not significant.
We also measured the levels of IL-4 in sera from pa-
tients in comparison with healthy controls. As shown in
Fig. 2b, levels of IL-4 in CE1 (2.84 ± 0.78 pg/ml), CE2
(3.78 ± 0.87 pg/ml), and CE3 (5.5 ± 0.96 pg/ml) groups
were significantly increased compared with those in the
healthy control group (2.1 ± 0.76 pg/ml) and CE4-5
(2.06 ± 0.67 pg/ml) group (CE1, p < 0.05; CE2, p < 0.05;
CE3, p < 0.05). The difference between CE4-5 and the
healthy controls was not statistically significant. The
level of IL-4 in CE2 was significantly increased com-
pared with that in CE1 (p < 0.05). Level of IL-4 in CE3
group was significantly increased compared with those
in CE2 and CE1 (p < 0.05, p < 0.05). Together, the above
results indicated that levels of both IL-21 and IL-4 are
increased in CE1, CE2, CE3 patients when compared
with those in the healthy controls and CE4-5 patients.
Changes in the transcripts of IL-21, IL-4, Bcl-6, and
Blimp-1 in CE patients
The mRNA levels of IL-21, IL-4, Bcl-6, and Blimp-1
were determined by real-time PCR. As shown in Fig. 3,
results showed that the expression levels of IL-21, IL-4,
and Bcl-6 were significantly increased in CE1, CE2, and
CE3 compared with those in the healthy control group
and CE4-5 (p < 0.05). The differences among CE1, CE2,
and CE3 groups were not statistically significant. The
mRNA levels of Blimp-1 in CE types were relatively
lower in comparison with those of IL-21, IL-4, Bcl-6.
And the difference was not statistically significant. These
results indicated that the mRNA levels of IL-21, IL-4,
and Bcl-6 are increased in progress of CE.
Changes in relative levels of antibodies in the progress
of CE
Since our results so far demonstrated that the percent-
ages of Tfh cells and the levels of cytokines and tran-
scription factors associated with Tfh cells in the
peripheral blood of CE patients (CE1-3) were increased
compared with those in CE4-5 and healthy controls, and
Tfh cells are known to influence the immunoglobulin
class switching, we studied the changes in relative
Fig. 2 Increased levels of IL-21 and IL-4 in CE patients. Serum samples were incubated with microbeads and detection reagents. The levels of
IL-21 and IL-4 in CE were measured by flow cytometry analysis. The differences of IL-21 (a) and IL-4 (b) in CE were compared
Fig. 3 Differential mRNA expression of IL-21, IL-4, Bcl-6, and Blimp-1 in PBMCs of CE patients. The expression of the mRNA levels of cytokines and
transcription factors were measured in total RNA isolated from the PBMCs by real-time RT-PCR. β-actin was used as an internal control. The mean
and SD were shown for each group. a The expression of IL-21 mRNA. b The expression of IL-4 mRNA. c The expression of Bcl-6 mRNA. d The
expression of Blimp-1 mRNA
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antibody levels and IgG subclasses in CE patients at dif-
ferent disease status with ELISA.
The relative levels of total IgG and subclasses (Fig. 4)
were changed in CE patients. The relative levels of total
IgG were increased in the CE1, CE2, and CE3 patients,
with CE3 patients have the highest relative level. Total
IgG relative levels in patients with CE1, CE2, CE3 were
higher than that in patients with CE4-5 and healthy
controls.
In the Eg infected patients, IgG1 and IgG4 were
mainly increased in patients with CE1, CE2, and CE3.
IgG1 and IgG3 in the patients with CE1, CD2 and CE3
were higher than that of healthy controls, and the peak
of IgG1 and IgG4 appeared at CE3. IgG1 and IgG4 rela-
tive levels in CE1, CE2 and CE3 patients were higher
than the healthy controls and CE4-5 patients.
The relative levels of IgG2 and IgG3 in CE4-5 patients
were higher than that in CE1, CE2 and CE3 patients,
and the IgG2 and IgG3 in Eg infected patients (CE1-
CE5) were increased compared with healthy controls,
which was in consistent with increased Tfh cytokines
and transcription factors observed in PBMC of patients.
Levels of IL-21 in CE1, CE2, and CE3 are positively
correlated with number of CCR7loPD-1hi cells within
CXCR5+ CD4+ T cells in CE patients
To determine correlation between levels of IL-21 and
IL-4 and the number of CCR7loPD-1hi cells within
CXCR5+ CD4+ T cells (circulating Tfh cells) in patients
with CE, we performed Pearson correlation analysis. The
results in Table 3 showed that the levels of IL-21 in CE1
(r = 0.529), CE2 (r = 0.551), and CE3 (r = 0.779) was
Fig. 4 The relative levels of IgG and subclasses in CE patients. E.granulosus antigen B-specific total IgG and IgG subclasses in the serum samples
were measured by ELISA. Means and SD were shown for each group. Different levels of IgG, IgG1, IgG2, IgG3, and IgG4 in CE patients were
compared. OD values of these IgGs in CE patients were normalized to those in healthy controls (negative control). a The relative level of total IgG
in CE patients’ sera. b The relative level of IgG1 in CE patients’ sera. c The relative level of IgG2 in CE patients’ sera. d The relative level of IgG3 in
CE patients’ sera. e The relative level of IgG4 in CE patients’ sera
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positively correlated with percentages of circulating Tfh
cells. However, the levels of IL-4 in all groups were not
correlated with circulating Tfh cells. These results sug-
gest that levels of IL-21, but not IL-4, in CE1, CE2, and
CE3 patients are positively correlated with percentages
of circulating Tfh cells.
Levels of circulating Tfh cells, IL-21 and IL-4 are increased
after in vitro stimulation with HF
To detect the levels of circulating Tfh cells, IL-21 and
IL-4 after in vitro stimulation with HF, we co-cultured
PBMCs isolated from healthy controls and CE patients
with HF or PBS. As shown in Fig. 5a, the percentage of
circulating Tfh cells was not increased after in vitro
stimulation with PBS. However, after stimulation with
HF, the percentage of circulating Tfh cells was signifi-
cantly higher in the PBMCs isolated from CE patients
than that from healthy individuals (p < 0.05). As shown
in Fig. 5b and Fig. 5c, PBS treatment did not increase
the levels of IL21 and IL-4 in culture supernatant. In
contrast, HF treatment increased the levels of IL21 and
IL-4 in culture supernatant. The levels of IL-21 and IL-4
in the supernatant were significantly higher in the
PBMCs from CE patients than those from healthy indi-
viduals (p < 0.05). Thus, after stimulating PBMCs from
CE patients with HF in vitro, levels of circulating Tfh
cells, IL-21 and IL-4 are increased.
Discussion
Similar to infections with other parasites in humans, Eg
evolves to obtain immune evasion capacity during the
chronic interaction with its host immunity. Studies with
animal models and clinical observations of humans in-
fected with hydatid diseases suggest that the host immun-
ity is dominated by Th2 cells, which mainly produces IL-4
Table 3 Correlations between circulating Tfh, IL-4, and IL-21
Circulating Tfh IL-4 IL-21
CE1 r −0.004 0.529
P >0.05 < 0.05
CE2 r −0.06 0.551
P > 0.05 < 0.05
CE3 r −0.169 0.779
P > 0.05 < 0.05
CE4-5 r −0.536 0.071
P > 0.05 > 0.05
Fig. 5 Analysis of circulating Tfh cells and IL-21 levels after in vitro stimulation. PBMCs were isolated from healthy individuals and CE patients.
Then they were stimulated with PBS or HF in vitro. The percentage of circulating Tfh cells was detected with flow cytometry. The levels of IL-21
and IL-4 were measured with cytometric bead array. a The percentage of circulating Tfh cells. b Level of IL-21 in the culture supernatant. c Level
of IL-4 in the culture supernatant
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with the increase of parasitic burden at the end stage of
the disease and is detrimental to the host protective im-
munity against parasite infection [1, 13]. Moreover, anti-
body class switching is obviously triggered at the
advanced stage of hydatid infection. The subclass of IgG is
different in different types of CE [7]. It is reported that the
Tfh cells influence the type and affinity of antibody pro-
duction during infection [29–31]. Our current study dem-
onstrated that Tfh cell numbers increased in patients with
CE1-3 but decreased in CE4-5 patients. In correlation
with this, the major Tfh cytokine IL-21 and IL-4 and tran-
scription factors Bcl-6 was also increased at the mRNA
levels in the PBMCs of patients with CE1-3 but not CE4-
5. The IgG subtype, levels of IgG1 and IgG4 were in-
creased in patients with CE1-3 and that of IgG2 and IgG3
was increased in patients with CE4-5. Together these data
suggest that Tfh cells in the peripheral blood of hydatid
infection change with diseases severity and are correlated
with changes in IgG subtype specific to certain diseases
spectra.
Compared with healthy controls, the frequency of per-
ipheral blood circulating Tfh cells was increased in CE1,
CE2, and CE3 patients. It is reported that circulating Tfh
cells is significantly increased in peripheral blood of sys-
temic lupus erythematosus, rheumatoid arthritis, and
human immunodeficiency virus patients, and was rapidly
increased in the vaccinated people [19, 20, 22]. In other
parasite infection, Tfh cells are also increased [23, 24].
The in vitro co-culture of PBMCs from CE patients
with HF induced the differentiation of circulating Tfh
cells in the present study. All these results showed
that circulating Tfh cells were significantly increased
in peripheral blood of CE, indicating that circulating
Tfh cells are involved in the immune response to CE
infection.
We also demonstrated that concentrations of IL-21
and IL-4 in peripheral blood were increased in CE1,
CE2, CE3, and those of patients with CE4-5 returned to
the levels close to healthy controls. IL-21 is critical for
the function of Tfh cells [18, 21], and it helps B cells to
produce high titer and high affinity antibodies against
their cognate antigens. B cells enter into follicle to form
germinal center and finally differentiate into the long-
acting plasma cells in T cell-dependent immune re-
sponses [31]. Moreover, IL-21 produced by Tfh cells pro-
motes the long-lasting plasma cells to produce high
affinity antibodies [32–34]. IL-21 cells play an important
role in the formation of Tfh cells and in the differenti-
ation, growth, survival, and transformation of B cells as
well [35, 36]. IL-4 is another cytokine produced by Tfh
cells and it is mainly produced by Tfh cells in the lymph
nodes of patients infected with parasite [37]. During the
chronic parasitic infection, IL-4 is indispensable for pro-
liferation of Th2 and B cells. B cells promote Tfh cells in
the germinal center to produce IL-4 and IL-21. These
two complementary cytokines are critical for differenti-
ation of Tfh cells while have little effect on the germinal
center formation [38, 39]. During the process of infec-
tion, expression level of IL-21 produced by Tfh cells is
much higher than IL-4 [40].
In the present study, levels of IL-21 and IL-4 were in-
creased in the active stage of CE, and level of IL-21 was
positively correlated with percentage of circulating Tfh
cells in the patients with active and transitional CE.
However, IL-4 level did not correlate with percentage of
circulating Tfh cells. Taken together, these results indi-
cate that IL-21 and IL-4 are involved in the immune re-
sponses against hydatid infection. Furthermore, the
mRNA levels of IL-21, IL-4, and Bcl-6 were increased in
CE1, CE2 and CE3. As the transcription factor of germi-
nal center Tfh cells, Bcl-6 is up-regulated in Tfh cells
and plays an important role in proliferation of GC Tfh
cells [41]. Blimp-1 inhibits expression of Bcl-6 in T cells
and promotes T cells to differentiate into other T cell
subtypes. Only Bcl-6 could determine the differenti-
ation of germinal center Tfh cells [27, 42, 43]. It is
reported that the mRNA level of Bcl-6 is moderately
expressed in systemic lupus erythematosus and
rheumatoid arthritis, but the mRNA level of Blimp-1
is very low [29, 30]. In the present study, the mRNA
level of Bcl-6 was increased in patients with active
and transitional CE infection, but the mRNA level of
Blimp-1 was very low in the same patients. It is dem-
onstrated that Tfh cells originated in the T-B border
region and follicles of lymph nodes may circulate into
the peripheral blood and form the Tfh cell compart-
ment [28]. The activated T cells with characteristics
of Tfh cells are closely related with the immune re-
sponses [18, 25, 26, 44]. Different from cells in lymph
nodes, Tfh cells in peripheral blood are in a quiescent
or memory state [25, 44]. Bcl-6 promotes proliferation
of T cells [44–46]. Bcl-6 is expressed in Tfh cells at
early differentiation in the T-B border, as well as in
Tfh cells in the follicles of lymph nodes [47–51].
In the progress of CE disease, two types of antigens
are exposed to the host immune system and induce
the production of antibodies. Laminated layer mate-
rials may contribute to the T-independent antibody
generation by active B cells. Our results indicate that
Eg infection up-regulate the mRNA level of Bcl-6 in
T cells (Additional file 1: Figure S1), and the Bcl-6
protein may not be expressed in these peripheral
blood Tfh cells because that these Tfh cells in the
peripheral blood coming from the secondary lymph-
oid organs may express the mRNA but not protein of
Bcl-6 [52–55]. Hence we did not study the expression
of Bcl-6 protein in peripheral blood Tfh cells in the
current study.
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Our results also demonstrated that level of total IgG
was increased in CE1, CE2, and CE3, and levels of IgG1,
IgG4 was increased in CE1, CE2, and CE3. This is con-
sistent with the previous reports. They reported that
level of IgG4 was increased in the active and transitional
CE, and that the seroprevalence of IgG4 was increased
whereas the levels of IgG1 and IgG4 were decreased in
CE4–5 [7, 9, 56].
Conclusion
Our study found that the circulating Tfh cells and re-
lated cytokines were closely related to the cyst stage.
Circulating Tfh cells not only involve in the immune re-
sponses initiated by Eg-infection, but also may be associ-
ated with IgG class switching during hydatid infection.
Additional file
Additional file 1: Figure S1. The schematic of circulating Tfh cells and
antibody formation in peripheral blood of CE. Eg can release a large
amount of Ag which may active Naive T cells by APC (antigen-present-
cell). Naive T cells express Bcl-6 and differentiate into effector T cells. Most
Bcl-6 high expression effector T cells develop into Tfh cells to help B cells
to produce antibodies in host Eg-infection. Some of Bcl-6 high expression
effector T cells move into peripheral blood and develop into circulating
Tfh cells, which can produce IL-21. (TIFF 188 kb)
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